View in EDS HTML Full Text PDF Full Text

Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial.

Saved in:
Bibliographic Details
Title: Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial.
Authors: Ostrowska-Leśko, Marta1 (AUTHOR) marta.ostrowska-lesko@umlub.pl, Mądry, Radosław2 (AUTHOR), Bobiński, Marcin1 (AUTHOR)
Source: Trials. 9/1/2025, Vol. 26 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-025-09062-8